# Shengjing Hospital: Observational study in Solid Neoplasms, Non-Small Cell Lung Cancer (900 participants)

**Score:** 55/100

| Field | Value |
|---|---|
| Sponsor | Shengjing Hospital |
| Sponsor type | Academic and hospital |
| Study | PET/CT-Based Intratumoral Heterogeneity and Multimodal Imaging for Tumor Diagnosis and Prognosis |
| NCT ID | NCT07906158 |
| Phase | Observational |
| Status | completed |
| Conditions | Solid Neoplasms; Non-Small Cell Lung Cancer |
| Intervention types | other |
| Target enrollment | 900 |
| Site countries | China |
| Posted | 2026-10-30 |
| Planned start | 2019-02-01 |
| Event | Newly registered study |
| Event date | 2026-10-30 |

## Why this score
- Posted in the last two weeks.
- 900 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07906158). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.